Latest News and Press Releases

CARMEL, Ind., May 22, 2017 (GLOBE NEWSWIRE) -- KAR Auction Services, Inc. (NYSE:KAR) (the “Company”) announced today that it plans to offer, subject to market conditions, approximately $800 million...

FRAMINGHAM, MA--(Marketwired - May 22, 2017) - Arch Therapeutics, Inc. (OTCQB: ARTH) ("Arch" or the "Company"), developer of novel liquid, gel and solid hemostatic and wound care devices, will be...

Revenue: $42.4 million in Q1Adjusted EBITDA: $25.9 million in Q1No debt maturities until August 2020Acquired five drybulk vessels – three Capesize and two Panamax vessels – for $113.9 millionFormed...

Meddelelse vedr. førtidsindfrielse af kapitalbeviser....

Restamax Plc STOCK EXCHANGE RELEASE 22 MAY 2017 at 14:30 JARNO SUOMINEN NAMED AS TEMPORARY CEO OF RESTAMAX PLC Restamax Plc's Board of Directors has named Jarno Suominen, 44, as the temporary CEO...

NEWARK, Calif., May 22, 2017 (GLOBE NEWSWIRE) -- Depomed, Inc. (Nasdaq:DEPO) today announced that following a comprehensive review of the Company's corporate governance practices, the Board of...

HAIFA, Israel, May 22, 2017 (GLOBE NEWSWIRE) -- Pluristem Therapeutics Inc. (Nasdaq:PSTI) (TASE:PSTI), a leading developer of placenta-based cell therapy products, today reported financial results...

Findings suggest Zilretta could potentially provide a cost-effective treatment option for patients with osteoarthritis of the knee BURLINGTON, Mass., May 22, 2017 (GLOBE NEWSWIRE) -- Flexion...

MENLO PARK, Calif., May 22, 2017 (GLOBE NEWSWIRE) -- A series of recent peer-reviewed scientific publications highlights the growing use of Single Molecule, Real-Time (SMRT®) Sequencing to annotate...

WALTHAM, Mass., May 22, 2017 (GLOBE NEWSWIRE) -- EyeGate Pharmaceuticals, Inc. (NASDAQ:EYEG) (“EyeGate” or the “Company”), a specialty pharmaceutical company that focuses on developing and...